About this trial
Previous studies have shown that screening for Barrett's esophagus (BE), the main risk factor for esophageal adenocarcinoma, is under-utilized in the primary care setting. In fact less than 35% of eligible patients are screened despite endorsement for screening by the major GI societies in patients with risk factors. The purpose of this study is to examine current screening practices and determine if implementation of screening reminders can optimize screening practices for Barrett's Esophagus within a large, academic based healthcare system in NJ.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years of age or older
Have a scheduled appointment with a participating provider
Disqualifiers
Less than 18 years of age
Trial design
Parallel
Treatments tested in this trial
Screening Reminder
Other interventionA reminder to screen this patient for Barrett's esophagus (BE) will be sent to the provider before the patient's scheduled appointment. The reminder will provide details about which criteria this patient meets in order to indicate that BE screening should be initiated.
Treatment groups
Trial outcomes
Primary outcomes
BE screening rate
Percentage increase in BE screening compared to each arm's historical control BE screening rate from the year prior.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: